Sexual issues and treatment side effects are not routinely discussed with men receiving treatment for prostate cancer, and support to address these concerns is not consistent across settings. This study evaluates a brief e-learning resource designed to improve sexual wellbeing support and examine its effects on healthcare professionals' sexual attitudes and beliefs. Healthcare professionals ( = 44) completed an online questionnaire at baseline which included a modified 12-item sexual attitudes and beliefs survey (SABS). Follow-up questionnaires were completed immediately after the e-learning and at 4 weeks. Data were analysed using one-way, repeat measures ANOVAs to assess change in attitudes and beliefs over time. Significant improvements were observed at follow-up for a number of survey statements including 'knowledge and understanding', 'confidence in discussing sexual wellbeing' and the extent to which participants felt 'equipped with the language to initiate conversations'. The resource was seen as concise, relevant to practice and as providing useful information on potential side effects of treatment. In brief, e-learning has potential to address barriers to sexual wellbeing communication and promote delivery of support for prostate cancer survivors. Practical methods and resources should be included with these interventions to support implementation of learning and long-term changes in clinical behaviour.
|Journal||International Journal of Environmental Research and Public Health|
|Early online date||24 Sep 2021|
|Publication status||Published - 1 Oct 2021|
Bibliographical noteFunding Information:
Funding: This research is supported by funding from the Movember Foundation and Prostate Cancer UK as part of the TrueNORTH maximizing sexual well-being project (TrueNTH/19).
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
- sexual wellbeing
- prostate cancer
- Attitude of Health Personnel
- Pilot Projects
- Computer-Assisted Instruction
- Prostatic Neoplasms - therapy
- Prostate cancer
- Sexual wellbeing
- Prostatic Neoplasms/therapy